| Name | Title | Contact Details |
|---|
Technology and Patent Research International, Inc. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
For over 25 years, Guaranteed Returns has provided pharmaceutical return services to hospital, government, independent retail, chain-store, LTC, Mail-Order and clinic pharmacies. Local GRx on-site service representatives are highly valued by customers for their professionalism, trustworthiness and for “going above and beyond”. Guaranteed Returns puts their longevity and industry knowledge to work to obtain the maximum amount of credits for every pharmacy return. GRx concentrates on providing pharmaceutical return solutions that address all aspects of the business, beginning with the manufacturer, through crediting the customer. Business review consultations, inventory management assistance and an unbeatable customer service department are just a few of the attributes that customers say sets GRx apart. Their flagship program, ReverseLink One™ has been branded as “the most cost effective return goods program ever to be offered by any 3rd party returns company”. Guaranteed Returns is dedicated to making pharmaceutical returns as simple as possible for customers while attaining the maximum amount of credits. Guaranteed Returns puts their 25 years of knowledge to work every day – continually investing in new programs, technologies and people - which is why GRx delivers Service You Can Count On.
GROVE INSTRUMENTS is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Worcester, MA. To find more information about GROVE INSTRUMENTS, please visit www.groveinstruments.com
At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach. In April 2021, Clinipace & dMed merged creating a differentiated mid-size CRO with the largest Asia-Pacific presence. We are proud to have such a strong group of global investors focused on improving healthcare outcomes and giving sponsors a better CRO choice. dMed`s 2019 acquisition of Target Health commenced the process of building a Next Generation global CRO for biotech and pharmaceutical companies. Our investors have invested over $230M to build the next great global CRO. dMed`s acquisition of Target Health in 2019 began dMed`s evolution from a local to global CRO. Target Health LLC is owned by dMedClinical Co. Ltd., a privately held company that is majority owned, operated, managed, and controlled by a U.S. citizen and foreign entities located in the People`s Republic of China. Dr. Lingshi Tan, is the aforementioned U.S. citizen currently residing in Shanghai, China. Dr. Tan moved to Shanghai (from New York) to become Pfizer`s VP of Worldwide Development Operations, and Chairman and General Manager of Pfizer (China) Research & Development Co. Dr. Tan founded dMed in 2016 to satisfy the local demand for a high quality, responsive, flexible CRO.
Mercy Health System is the largest Catholic healthcare system serving the Delaware Valley and is a member of Catholic Health East, a multi-institutional, Catholic health system co-sponsored by 13 religious congregations and Hope Ministries.